Heartland Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,241
Closed -$1.47M 196
2022
Q1
$1.47M Buy
13,241
+4,115
+45% +$435K 0.09% 186
2021
Q4
$944K Sell
9,126
-3,865
-30% -$448K 0.06% 201
2021
Q3
$1.63M Sell
12,991
-49
-0.4% -$6.34K 0.1% 199
2021
Q2
$1.62M Buy
13,040
+24
+0.2% +$3.01K 0.09% 210
2021
Q1
$1.54M Sell
13,016
-379
-3% -$44.4K 0.1% 208
2020
Q4
$1.57M Sell
13,395
-23,369
-64% -$2.57M 0.11% 199
2020
Q3
$3.82M Sell
36,764
-254
-0.7% -$25.5K 0.33% 125
2020
Q2
$3.4M Buy
37,018
+9,999
+37% +$959K 0.3% 131
2020
Q1
$2.44M Buy
+27,019
New +$2.87M 0.26% 135

Other funds holding MDT

Heartland Advisors's MDT Position: Q2 2022 in Review

Heartland Advisors sold out of Medtronic (MDT) in Q2 2022, closing a stake of 13,241 shares — an estimated $1.47M sold.

Heartland Advisors first reported a position in MDT in Q1 2020 and held it in 9 quarters. The position peaked at $3.82M in Q3 2020. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Heartland Advisors reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Heartland Advisors sold 13,241 Medtronic shares in Q2 2022, an estimated $1.47M.
  • Heartland Advisors first reported a position in Medtronic in Q1 2020 and held it in 9 quarters.
  • Heartland Advisors's Medtronic position peaked at $3.82M in Q3 2020.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Heartland Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.